HE3286
- Generic Name
- HE3286
- Drug Type
- Small Molecule
- Chemical Formula
- C21H30O3
- CAS Number
- 1001100-69-1
- Unique Ingredient Identifier
- PH8858757I
- Indication
For the treatment of rheumatoid arthritis and type 2 diabetes.
NE3107 in Adults With Neurological Symptoms of Long COVID
- First Posted Date
- 2025-02-26
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- BioVie Inc.
- Target Recruit Count
- 208
- Registration Number
- NCT06847191
- Locations
- 🇺🇸
Clinical Trial Site, Farmington Hills, Michigan, United States
A Study of NE3107 in Early Parkinson's
- First Posted Date
- 2025-01-03
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- BioVie Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06757010
- Locations
- 🇺🇸
Invicro, New Haven, Connecticut, United States
🇺🇸Northwestern Medicine, Chicago, Illinois, United States
🇺🇸Quest Research Institute, Farmington Hills, Michigan, United States
Insulin-sensitizing NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain Injury
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Neurological Associates of West Los Angeles
- Target Recruit Count
- 5
- Registration Number
- NCT05970575
- Locations
- 🇺🇸
The Regenesis Project, Santa Monica, California, United States
Insulin-Sensitizing Anti-Inflammatory Small Molecule for Investigative Treatment of Dementia
- First Posted Date
- 2022-02-07
- Last Posted Date
- 2024-07-09
- Lead Sponsor
- Neurological Associates of West Los Angeles
- Target Recruit Count
- 23
- Registration Number
- NCT05227820
- Locations
- 🇺🇸
Neurological Associates - The Interventional Group, Santa Monica, California, United States
NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa
- First Posted Date
- 2021-10-19
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- BioVie Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT05083260
- Locations
- 🇺🇸
Parkinson's Disease & Movement Disorders Center Of Boca Raton, Boca Raton, Florida, United States
🇺🇸Charter Research, Winter Park, Florida, United States
🇺🇸University of Toledo, Toledo, Ohio, United States
A Phase 3 Study of NE3107 in Probable Alzheimer's Disease
- First Posted Date
- 2020-12-16
- Last Posted Date
- 2023-11-21
- Lead Sponsor
- BioVie Inc.
- Target Recruit Count
- 439
- Registration Number
- NCT04669028
- Locations
- 🇺🇸
The Ohio State University, Columbus, Ohio, United States
A Study of the Safety, Tolerance and Assessment of HE3286 on Insulin Sensitivity and Hepatic Glucose Production
- First Posted Date
- 2009-10-07
- Last Posted Date
- 2011-03-09
- Lead Sponsor
- Harbor Therapeutics
- Target Recruit Count
- 5
- Registration Number
- NCT00991107
- Locations
- 🇺🇸
Clinical Site, Baton Rouge, Louisiana, United States
Safety, Tolerance, Pharmacokinetics and Activity of HE3286 in Patients With Rheumatoid Arthritis
- First Posted Date
- 2008-07-09
- Last Posted Date
- 2011-06-14
- Lead Sponsor
- Harbor Therapeutics
- Target Recruit Count
- 14
- Registration Number
- NCT00712114
Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes Mellitus
- First Posted Date
- 2008-06-10
- Last Posted Date
- 2011-06-14
- Lead Sponsor
- Harbor Therapeutics
- Target Recruit Count
- 164
- Registration Number
- NCT00694057
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
- First Posted Date
- 2008-03-05
- Last Posted Date
- 2011-06-14
- Lead Sponsor
- Harbor Therapeutics
- Target Recruit Count
- 27
- Registration Number
- NCT00628433
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.